Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.

Link to article at PubMed

Related Articles

Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b.

Int J Antimicrob Agents. 2020 Jun 13;:106052

Authors: Hong SI, Ryu BH, Chong YP, Lee S, Kim S, Kim HC, Hong KW, Bae IG, Cho OH

PMID: 32544570 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.